BindingDB logo
myBDB logout

BDBM332495 4-(1-(2-chloro-6-trifluoromethylbenzoyl)-6-(pyridin-3-yl)-1H-indazol-3-yl)benzoic acid (23A)::US10196354, Example 23A::US9745265, 23A

SMILES: OC(=O)c1ccc(cc1)-c1nn(C(=O)c2c(Cl)cccc2C(F)(F)F)c2cc(ccc12)-c1cccnc1

InChI Key: InChIKey=NGUYRHAASNRWFS-UHFFFAOYSA-N

Data: 2 IC50

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 332495   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Nuclear receptor ROR-gamma


(Mus musculus)
BDBM332495
PNG
(4-(1-(2-chloro-6-trifluoromethylbenzoyl)-6-(pyridi...)
Show SMILES OC(=O)c1ccc(cc1)-c1nn(C(=O)c2c(Cl)cccc2C(F)(F)F)c2cc(ccc12)-c1cccnc1
Show InChI InChI=1S/C27H15ClF3N3O3/c28-21-5-1-4-20(27(29,30)31)23(21)25(35)34-22-13-17(18-3-2-12-32-14-18)10-11-19(22)24(33-34)15-6-8-16(9-7-15)26(36)37/h1-14H,(H,36,37)
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a>1.00E+4n/an/an/an/an/an/a



Merck Sharp & Dohme Corp.

US Patent


Assay Description
To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T...


US Patent US9745265 (2017)

More data for this
Ligand-Target Pair
Nuclear receptor ROR-gamma


(Homo sapiens (Human))
BDBM332495
PNG
(4-(1-(2-chloro-6-trifluoromethylbenzoyl)-6-(pyridi...)
Show SMILES OC(=O)c1ccc(cc1)-c1nn(C(=O)c2c(Cl)cccc2C(F)(F)F)c2cc(ccc12)-c1cccnc1
Show InChI InChI=1S/C27H15ClF3N3O3/c28-21-5-1-4-20(27(29,30)31)23(21)25(35)34-22-13-17(18-3-2-12-32-14-18)10-11-19(22)24(33-34)15-6-8-16(9-7-15)26(36)37/h1-14H,(H,36,37)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a>1.00E+4n/an/an/an/an/an/a



Merck Sharp & Dohme Corp.

US Patent


Assay Description
The compounds of the invention inhibit RORgammaT activity. Activation of RORgammaT activity can be measured using, e.g., biochemical TR-FRET assay. I...


US Patent US10196354 (2019)

More data for this
Ligand-Target Pair